Skip to content
Vision Dice Desk

Zimbabwe Declines ‘Unbalanced’ American Health Aid Package Due to Data Apprehensions

Medical funding image
The offered US funding would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has declined a significant American healthcare agreement valued at $367m (272 million pounds) spanning five years because of Washington's demand for sensitive data.

The decision came to light following a official document from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".

A government spokesperson later stated that the US was demanding access to health data for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from any future vaccines.

"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has called for continued dialogue to secure a deal agreeable to all parties so the country's vital HIV programme can be sustained.

Wider Implications

This rejection comes after a similar case in Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the safety of Kenyans' health data.

After returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

USAID had managed assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and accountability.

Based on statements, Sixteen nations in Africa have to date agreed to these new agreements, representing more than $18.3bn in new funding.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.

"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be accessible to our population should a new pandemic emerge."

Sovereignty and Global Health

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks previously set up through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.

"This system is designed to ensure that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."

The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.

"We encourage continued discussions with our American counterparts on how future collaboration might be arranged in a manner that respects the independence and interests of each country."

Medical Community Response

A leading public health body stated it acknowledged the official position, but recommended that talks should continue given that a large portion of the nation's HIV programmes were funded by external financing.

"In cases where technical issues exist, such as those relating to information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.

The halted deal underscores the ongoing challenges between accepting much-needed international aid and protecting a country's data in an ever more data-driven world.

PF
About the author

Patricia Franco

Elara Vance is a digital strategist and creative consultant with over a decade of experience in tech innovation and brand development.

Vision Dice Desk

Type to search articles.